Michael Swarbrick is a Senior Research Fellow in the Centre for Diabetes, Obesity and Endocrinology at The Westmead Institute. Michael completed his PhD at the University of Western Australia, performing genetic studies in humans to identify candidate genes for obesity. This was followed by postdoctoral work at the University of California (San Francisco and Davis campuses), where he conducted studies in large human cohorts to identify new candidate genes for severe obesity (GAD2, SIM1). Michael also undertook a comprehensive analysis of the endocrine changes following bariatric surgery-assisted weight loss; and contributed to dietary studies investigating the metabolic effects of fish oil and sugar-sweetened beverages on obese and overweight humans. Michael joined The Westmead Institute in 2014.